Results 31 to 40 of about 235 (94)

A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. [PDF]

open access: yesJ Pharmacokinet Pharmacodyn, 2023
Ruiz-Garcia A   +14 more
europepmc   +1 more source

Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. [PDF]

open access: yesMolecules, 2023
Tomarchio R   +6 more
europepmc   +1 more source

Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing. [PDF]

open access: yesCell Rep Med, 2023
Liu C   +11 more
europepmc   +1 more source

Pleural effusion in hematological pathology. [PDF]

open access: yesCytojournal, 2021
Yerrapotu N   +3 more
europepmc   +1 more source

Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein

open access: yesHaematologica, 2019
Haruka Shinohara   +3 more
doaj   +1 more source

Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review. [PDF]

open access: yesFront Physiol, 2021
Santoro M   +5 more
europepmc   +1 more source

Establishment of a FDC-P1 Murine Cell Line with Human KIT N822K Gene Overexpression. [PDF]

open access: yesActa Naturae, 2020
Vagapova ER   +5 more
europepmc   +1 more source

Iron Deficiency Caused by Intestinal Iron Loss-Novel Candidate Genes for Severe Anemia. [PDF]

open access: yesGenes (Basel), 2021
Huettmann C   +12 more
europepmc   +1 more source

Senotherapeutics in Cancer and HIV. [PDF]

open access: yesCells, 2022
Sánchez-Díaz L   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy